Chapter 40. Pharmacologic Intervention: Lipid-Lowering Agents

  1. Rodney A. White MD1 and
  2. Larry H. Hollier MD2
  1. Ralph G. DePalma

Published Online: 4 OCT 2007

DOI: 10.1002/9780470987094.ch40

Vascular Surgery: Basic Science and Clinical Correlations, Second Edition

Vascular Surgery: Basic Science and Clinical Correlations, Second Edition

How to Cite

DePalma, R. G. (2007) Pharmacologic Intervention: Lipid-Lowering Agents, in Vascular Surgery: Basic Science and Clinical Correlations, Second Edition (eds R. A. White and L. H. Hollier), Blackwell Publishing, Malden, Massachusetts, USA. doi: 10.1002/9780470987094.ch40

Editor Information

  1. 1

    Professor of Surgery, UCLA School of Medicine, Chief, Division of Vascular Surgery, Harbor-UCLA Medical Center, Torrance, California

  2. 2

    Dean, Louisiana State University School of Medicine in New Orleans, New Orleans, Louisiana

Publication History

  1. Published Online: 4 OCT 2007
  2. Published Print: 15 MAR 2005

ISBN Information

Print ISBN: 9781405122023

Online ISBN: 9780470987094

SEARCH

Keywords:

  • lipid-lowering agents;
  • low-density lipoprotein cholesterol (LDLC);
  • cholesterol-lowering atherosclerosis studies (CLAS);
  • probucol;
  • LDL oxidation

Summary

This chapter contains sections titled:

  • Indications

  • Standard drugs in the United States

  • Clinical correlates

  • Acknowledgment